Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Voting Common Stock	Non-voting Common Stock	Common Stock Voting Common Stock	Common Stock Non-voting Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income	Accumulated Deficit
Balances at Dec. 31, 2023	$ 150,867			$ 4	$ 1	$ 398,459		$ (247,597)
Balances, shares at Dec. 31, 2023				43,552,941	4,276,588
Exercise of stock options	1,717					1,717
Exercise of stock options, shares				586,081
Issuance of common stock under employee stock purchase plan	333					333
Issuance of common stock under employee stock purchase plan, shares				82,153
Issuance of common stock, net of offering costs	33,131			$ 1		33,130
Issuance of common stock, net of offering costs, shares				4,958,068
Issuance of pre-funded warrants, net of offering costs	158,071					158,071
Conversion of convertible debt	14,750					14,750
Conversion of convertible debt, shares				3,134,796
Stock-based compensation expense	9,549					9,549
Net loss	(127,499)							(127,499)
Unrealized gain (loss) on available-for-sale securities	51						$ 51
Balances at Dec. 31, 2024	240,970			$ 5	$ 1	616,009	51	(375,096)
Balances, shares at Dec. 31, 2024		52,314,039	4,276,588	52,314,039	4,276,588
Issuance of common stock under employee stock purchase plan	264					264
Issuance of common stock under employee stock purchase plan, shares				234,826
Issuance of common stock upon exercise of pre-funded warrants				76,170
Stock-based compensation expense	11,706					11,706
Net loss	(129,766)							(129,766)
Unrealized gain (loss) on available-for-sale securities	(51)						$ (51)
Balances at Dec. 31, 2025	$ 123,123			$ 5	$ 1	$ 627,979		$ (504,862)
Balances, shares at Dec. 31, 2025		52,625,035	4,276,588	52,625,035	4,276,588